News & Sentiment
24/7 Digital Marketing Introduces “Autopilot Enquiry System” for Consistent 20-30 Qualified Monthly Lead Generation
Multi-Brand Expansion Introduces Specialized Marketing Ecosystems for Legal, Real Estate, FinTech, and Home Services Industries. Multi-Brand Expansion Introduces Specialized Marketing Ecosystems for Legal, Real Estate, FinTech, and Home Services Industries.
All
Basic Materials
Communication Services
Consumer Cyclical
Consumer Defensive
Energy
Financial Services
Healthcare
Industrials
Real Estate
Technology
Utilities
Macro
All Sentiment
Bullish
Neutral
Bearish
169 articles
Dyne Therapeutics Announces Initiation of Phase 3 FORZETTO Trial of Z-Rostudirsen in Duchenne Muscular Dystrophy (DMD) Ahead of Planned BLA Submission for U.S. Accelerated Approval
- 72-week trial will enroll approximately 90 participants; first site now open for enrollment -
📰
Skye Announces Cohort Review Committee Approved Opening of Cohort 2 Based on Favorable Safety Data from First Four Participants Treated in Cohort 1
No Serious Adverse Events or Adverse Events of Special Interest Were Reported Following 4 Weeks of Treatment No Serious Adverse Events or Adverse...
GeoRedox and Canada Nickel Launch First-of-its-kind Geologic Hydrogen Program at Crawford Nickel Project in Timmins, Ontario
Highlights: MOU signed to develop first stimulated geologic hydrogen well at Crawford Nickel Project, Timmins, Ontario Zero-carbon hydrogen to be...
Miami International Holdings Announces OCC Clearing and Settlement Agreement for MIAX Futures Exchange
MIAMI and PRINCETON, N.J., May 20, 2026 /PRNewswire/ -- Miami International Holdings, Inc. (MIAX®) (NYSE: MIAX), a technology-driven leader in...
Co-Diagnostics Announces $3.0 Million Private Placement Priced At-The-Market Under Nasdaq Rules
SALT LAKE CITY, May 19, 2026 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) ("Co-Dx", or the "Company"), a molecular diagnostics company with a...
Antengene Appoints Dr. Bing Hou as Chief Scientific Officer to Lead Innovation-Driven R&D Strategy and Advance Next-Generation Pipeline
SHANGHAI and HONG KONG, May 19, 2026 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative,...
FIRST STUDENT TEAMSTERS RATIFY NATIONAL MASTER AGREEMENT
Five-Year Deal Strengthens Protections and Raises Standards Nationwide WASHINGTON, May 19, 2026 /PRNewswire/ -- Teamsters at First Student have...
Ultra Maritime Secures New Contract to Strengthen Royal Australian Navy's Undersea Defence Capabilities
ADELAIDE, Australia, May 19, 2026 /PRNewswire/ -- Ultra Maritime Australia has been awarded a contract by the Australian Department of Defence to...
📰
Monopar Announces Publication of Phase 2 Study Demonstrating ALXN1840 Significantly Improves Copper Balance in Patients with Wilson Disease
WILMETTE, Ill., May 19, 2026 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (“Monopar” or the “Company”) (Nasdaq: MNPR), a clinical-stage...
📰
Eton Pharmaceuticals Expands Rare Disease Portfolio Through Agreement for U.S. Commercialization Rights to IMPAVIDO® (miltefosine)
DEER PARK, Ill., May 19, 2026 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (“Eton” or “the Company”) (Nasdaq: ETON), an innovative pharmaceutical...
Компания CHERY официально объявила Роберта Левандовски глобальным послом бренда CHERY, укрепив тем самым международное признание философии бренда «For Family»
БАРСЕЛОНА, Испания, 19 мая 2026 г. /PRNewswire/ -- CHERY официально объявила в своем Европейском операционном центре в Барселоне, что легенда...
The Quiet Engineering Move That Could Define How a Cape Canaveral Air-Launch Operator Gets to Flight
Issued on behalf of Starfighters Space, Inc. Starfighters Space (NYSE American: FJET) just brought in a deep-bench engineering and integration...
📰
HeartSciences Signs Commercial Agreement with North Shore Health, the First Hospital Deployment from the Cibolo Health Network
Agreement follows Cibolo Health’s endorsement of MyoVista Insights for its network of 127 independent hospitals and reflects continued commercial...
📰
Nexalin Acquires AI-Integrated Digital Health Platform Behind HALO™ Clarity and Nexalin NeuroCare™ Ahead of Planned FDA Pivotal Trial
Acquisition gives Nexalin control of AI-integrated remote patient-monitoring, clinical data-capture and virtual-care infrastructure already deployed...
📰
NKGen Biotech Expands Clinical Trial Site Network for Alzheimer’s Disease Program Across U.S. to Improve Patient Access and Support Enrollment
New sites in New Jersey, New York, and Florida broaden geographic reach and increase access for patients participating in Phase 2 trial of...
📰
Rocket Doctor Enters into North Star Agreement
Vancouver, BC, May 19, 2026 (GLOBE NEWSWIRE) -- Rocket Doctor AI Inc. (CSE: AIDR, OTC: AIRDF, Frankfurt: 939) (“Rocket Doctor AI”) announces that,...
📰
Bone Biologics Achieves 29-Month Validated Shelf Life for rhNELL-1
Milestone advances commercial and manufacturing readiness ahead of anticipated pivotal study scale-up Milestone advances commercial and manufacturing...
📰
Bone Biologics Achieves 29-Month Validated Shelf Life for rhNELL-1
Milestone advances commercial and manufacturing readiness ahead of anticipated pivotal study scale-up Milestone advances commercial and manufacturing...
📰
Quantum Cyber Files Non-Provisional Patent Application With the USPTO for EMP-Shielding 3D-Printable Composite Filament for Drone and Defense Electronics
Patent Claims Broadband EMP and EMI Shielding Effectiveness for Unmanned Aerial Vehicle Electronics Enclosures; No Publicly Listed Drone Defense...
📰
Korro Selects KRRO-111 as Development Candidate for the Potential Treatment of Alpha-1 Antitrypsin Deficiency (AATD)
CAMBRIDGE, Mass., May 19, 2026 (GLOBE NEWSWIRE) -- Korro Bio, Inc. (Korro) (Nasdaq: KRRO), a biopharmaceutical company leveraging a novel...
📰
Quantum Cyber Files Patent with USPTO for Autonomous Naval Mine Countermeasure System Addressing Iran's Mining of the Strait of Hormuz and Trump Administration Homeland Security Priorities
UAV-Deployed Autonomous Survey and Neutralization Technology Addresses Documented U.S. Navy Capability Gap in World's Most Critical Maritime...
📰
Cullinan Therapeutics Receives FDA Orphan Drug Designation for CLN-049, a Novel FLT3xCD3 T Cell Engager, in Relapsed/Refractory Acute Myeloid Leukemia
Orphan Drug Designation underscores the potential of CLN-049, a novel FLT3xCD3 T cell engager, to address significant unmet need in AML
Tiziana Announces New Positive Clinical Data for Intranasal Foralumab in Non-Active Secondary Progressive Multiple Sclerosis
BOSTON, May 19, 2026 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) ("Tiziana"), a biotechnology company developing its lead...
📰
ECARX and May Mobility to Scale Autonomous Ride-Hail Fleet
Strategic Framework Alliance to Power Next-Generation Turnkey Autonomous Vehicle Development ECARX to Develop High Performance AI Compute System for...
Global Cell Culture Media Market Outlook 2026-2036: Biologics Manufacturing and Cell Therapy Expansion Accelerate Growth for Avantor, Thermo Fisher Scientific, and Lonza Group AG
NEWARK, Del., May 19, 2026 /PRNewswire/ -- According to the latest market analysis by Future Market Insights (FMI), the global Cell Culture Media...
Immunic Appoints Seasoned Biopharmaceutical Executive Michael W. Bonney as Chair of the Board of Directors
– More Than 30 Years of Leadership Experience Across Biopharmaceutical Commercialization – – Played Key Role in the Launch and Commercial Success of...
📰
Planet 13 Receives OMMU Approval for Florida BHO Extraction Facility
LAS VEGAS, May 19, 2026 (GLOBE NEWSWIRE) -- Planet 13 Holdings Inc. (CSE: PLTH) (OTCQX: PLNH) (“Planet 13” or the “Company”), a leading...
Hut 8 Commits $16 Million to Expand Water Infrastructure in West Feliciana Parish
Investment expected to increase long-term system capacity alongside development of River Bend AI data center campus BATON ROUGE, La., May 19, 2026...
📰
Relay Therapeutics Announces Initial Clinical Data Demonstrating That Zovegalisib Has Potential for Differentiated Safety and Efficacy in Patients with PIK3CA-Driven Vascular Anomalies
Promising initial efficacy data with 60% volumetric response rate across doses and 29%* at the lowest tested dose of 100mg twice daily (BID) with all...
Queen Mary University of London and MCatalysis Awarded EPSRC and Defra Grant to Revolutionize Medical Waste Upcycling
LONDON, May 19, 2026 /PRNewswire/ -- Queen Mary University of London (QMUL) and deep-tech company MCatalysis, Inc. have been awarded a strategic...
DNA Finland Extends Fiber-Grade Connectivity to Lower-Density MDUs with Harmonic
Harmonic's SeaStar Optical Node Enables Cost-Effective Broadband Service Expansion in Previously Underserved Brownfield MDU Environments SAN JOSE,...
Power Metallic Announces Expansion In the Kingdom of Saudi Arabia via Joint Venture With Amaar Mining
Strategic partnership establishes a framework for Power Metallic and Amaar Mining to jointly pursue future Saudi mining license auction rounds, with...
Fujitsu, SMBC Group and SoftBank agree on alliance to build Japan-made platform for sustainable healthcare
Companies aim to extend healthy life expectancy, optimize management of healthcare institutions, and curb national healthcare costs Sumitomo Mitsui...
BIOTRONIK, Charité, and German Heart Center Foundation Announce Partnership to Advance Digital Cardiology
Strategic Initiative Strengthens Berlin as Europe's Hub of Digital Cardiology BERLIN, May 19, 2026 /PRNewswire/ -- BIOTRONIK, die Charité –...
JinkoSolar Strengthens Collaboration with PM Green: 1 GW Agreement Signed, Including 200 MW of Tiger Neo 3.0 Modules
FLORENCE, Italy, May 19, 2026 /PRNewswire/ -- JinkoSolar, the global leading PV and ESS supplier, recently announced today the signing of a major...
📰
Roche to present new data at ASCO 2026, reinforcing giredestrant's potential to transform the treatment paradigm in early breast cancer
Basel, 19 May 2026 - Roche (SIX: RO, ROP; OTCQX: RHHBY) will present new data from nine approved and investigational medicines across more than 15...
T-Global Technology s'associe à SiPearl (France) pour faire progresser les technologies de refroidissement des puces HPC de nouvelle génération
TAIPEI, 19 mai 2026 /PRNewswire/ -- T-Global Technology a annoncé aujourd'hui que son projet phare, « Développement de matériaux à haute conductivité...
📰
Leads Biolabs' PD-L1/4-1BB Bispecific Antibody Wins Pivotal Phase III Approval, Set to Reshape the Frontline Treatment Landscape for Advanced EP-NEC
NANJING, China, May 18, 2026 /PRNewswire/ -- Nanjing Leads Biolabs Co., Ltd. ("Leads Biolabs" or the "Company," Stock Code: 9887.HK) today announced...
Red Apple Group Selects FirstService Residential to Manage The Residences at 400 Central
FirstService Residential to deliver property management and lifestyle services to the tallest residential building on Florida's west coast ST....
📰
Pennant Announces an Acquisition of Senior Living Community in Arizona
EAGLE, Idaho, May 18, 2026 (GLOBE NEWSWIRE) -- The Pennant Group, Inc. (NASDAQ: PNTG), the parent company of the Pennant group of affiliated home...
📰
Cullinan Therapeutics to Present Initial Clinical Data for CLN-978 in Treatment-Refractory Rheumatoid Arthritis and Systemic Lupus Erythematosus at EULAR 2026 Congress
CAMBRIDGE, Mass., May 18, 2026 (GLOBE NEWSWIRE) -- Cullinan Therapeutics, Inc. (Nasdaq: CGEM), a clinical-stage biopharmaceutical company...
📰
IPAX-2 Study of TLX101-Tx in First-line Glioblastoma Completes Enrolment and Confirms Dosing
MELBOURNE, Australia and INDIANAPOLIS, May 19, 2026 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, “Telix”) today...
📰
Wave Life Sciences Announces Positive Update on RestorAATion-2 Trial: WVE-006 (GalNAc-RNA Editing) Achieves MZ-Like Phenotype Across Both Biweekly and Monthly Dosing
Data reinforce WVE-006’s potential to address both lung and liver manifestations of AATD with a durable, convenient, and safe therapy capable of...
📰
Mineralys Therapeutics Announces Presentation of New Data from the Phase 3 Launch-HTN Trial of Lorundrostat at the 35th European Meeting on Hypertension and Cardiovascular Protection (ESH 2026)
– Oral presentation highlights efficacy and safety profile of lorundrostat in patients with uncontrolled hypertension and chronic kidney disease –
📰
C4 Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
WATERTOWN, Mass., May 18, 2026 (GLOBE NEWSWIRE) -- C4 Therapeutics, Inc. (C4T) (Nasdaq: CCCC), a clinical-stage biopharmaceutical company dedicated...
Společnost CHERY oficiálně oznámila jmenování Roberta Lewandowského globálním ambasadorem značky CHERY, čímž posílila globální prosazování filozofie značky „For Family"
BARCELONA, Španělsko, 18. května 2026 /PRNewswire/ -- Značka CHERY ve svém evropském operačním centru v Barceloně oficiálně oznámila, že se k ní...
B7-H3 Becomes The Hottest Antigen In Oncology, And One NK Engager Enters Clinic
Issued on behalf of GT Biopharma, Inc. SAN FRANCISCO, May 18, 2026 /PRNewswire/ -- USA News Group News Commentary — For more than two decades, B7-H3...